A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2023-08-16
AEs
4
Serious
1
Dropout signal
–
Adverse events
mild
assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-01-25 (study day 153); relationship: N
moderate
assessed
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-05-31 (study day 280); relationship: N
severe
serious
assessed
Grade 3 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2024-08-30 (study day 371); relationship: not assessed; serious criteria: hospitalization
mild
assessed
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2024-11-21 (study day 454); relationship: N
Data queries
No data queries.